Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Precision Optics Corporation, Inc. (POCI) Q4 2026 Earnings Call Transcript

29 September 2026

Royal Gold, Inc. (RGLD) Presents at Mining Forum Americas 2026 Transcript

28 September 2026

Zymeworks Inc. (ZYME) M&A Call Transcript

28 September 2026

Meta: More Cautious Than Before, More Bullish Than Ever (NASDAQ:META)

28 September 2026

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript

28 September 2026
Facebook X (Twitter) Instagram
Business Tuesday, Sep 29
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » Change Financial Limited (CNGFF) Q4 2026 Earnings Call Transcript
News

Change Financial Limited (CNGFF) Q4 2026 Earnings Call Transcript

thebusinesstimes.co.ukBy thebusinesstimes.co.uk24 July 20262 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Change Financial Limited (CNGFF) Q4 2026 Earnings Call Transcript
Share
Facebook Twitter LinkedIn Pinterest Email

Tony Sheehan
Chief Executive Officer

[Audio Gap] I’m joined by Tom Russell, Executive Director. Similar to our usual webinar format, Tom and I will run through a presentation and then take Q&A at the end. We’ve received a lot of questions ahead of the webinar. So we will run through the presentation pretty quickly today, touching on the key highlights for Q4 and the outlook before responding to all the questions we have received. If you have any questions during the webinar, please submit them through the chat function that’s available.

Slide 2, I’m going to skip through this slide. We’ve been through it numerous times over the course of our webinars. I think the only key update really to take away here: Vertexon, 83% of FY ’26 revenue, with PaySim generating the remaining 17%.

In terms of key highlights, so continued revenue growth in Q4 as we delivered revenue of $4.6 million up 16% on prior year. FY ’26 revenue was up 21% on FY ’25 with 73% of revenue derived from recurring sources, which provides a very solid base of revenue to grow from. From a revenue perspective, we have more than doubled the size of the business over the last 3 years, delivering a 3-year CAGR of 28%. Underlying EBITDA for the quarter was $800,000, taking total FY ’26 underlying EBITDA to $3.3 million, a 17-fold increase over FY ’25.

The operating leverage we’ve spoken about, the combination of revenue growth and a stable fixed cost base has driven a materially improved bottom line performance during the year. Tom will cover this in more detail, but we have realized significant gross margin expansion

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Precision Optics Corporation, Inc. (POCI) Q4 2026 Earnings Call Transcript

Royal Gold, Inc. (RGLD) Presents at Mining Forum Americas 2026 Transcript

Zymeworks Inc. (ZYME) M&A Call Transcript

Meta: More Cautious Than Before, More Bullish Than Ever (NASDAQ:META)

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript

Bitcoin: The Beginning Of The Next Bull Market (Cryptocurrency:BTC-USD)

Crown Castle: Buy This High Yield While It’s Undervalued (NYSE:CCI)

BitGo: Down 55% From The IPO, With A Bank Charter And No Debt (NYSE:BTGO)

Kinross Gold: The Pullback I Waited For Came With Damage Attached (NYSE:KGC)

Editors Picks

Royal Gold, Inc. (RGLD) Presents at Mining Forum Americas 2026 Transcript

28 September 2026

Zymeworks Inc. (ZYME) M&A Call Transcript

28 September 2026

Meta: More Cautious Than Before, More Bullish Than Ever (NASDAQ:META)

28 September 2026

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript

28 September 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

Bitcoin: The Beginning Of The Next Bull Market (Cryptocurrency:BTC-USD)

28 September 2026

'Chancellor John Healey's Budget will reveal winners and losers as hope meets reality next month'

28 September 2026

Crown Castle: Buy This High Yield While It’s Undervalued (NYSE:CCI)

28 September 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.